Levetiracetam in Central Pain in Multiple Sclerosis(MS)
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Multiple sclerosis is often associated with pain. There is no standard treatment of this type
of pain. Levetiracetam is a new anticonvulsant and it is the hypothesis that it could relieve
central pain in multiple sclerosis. This is a randomised, double-blind, placebo-controlled,
cross-over trial on the effect of levetiracetam 3000 mg daily on pain in multiple sclerosis.